Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 903 of 6351
-
New drug combo shows promise for tough head and neck cancers
Disease control OngoingPembrolizumab monotherapy and platinum-based chemotherapy in the combination with pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) have been widely used in daily clinical practice based on the KEYNOTE-048 study. On the other hand, doceta…
Phase 2 • Sponsor: Hokkaido University Hospital • Aim: Disease control
Last updated Jun 26, 2026 16:28 UTC
-
New drug shows promise for SMA patients in major trial
Disease control OngoingThis trial will study the efficacy and safety of taldefgrobep alfa as an adjunctive therapy for participants who are already taking a stable dose of nusinersen and/or risdiplam and/or have a history of onasemnogene abeparvovec, compared to placebo.
Phase 3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Engineered immune cells take aim at childhood cancers
Disease control Recruiting now3CAR is being done to investigate an immunotherapy for patients with solid tumors. It is a Phase I clinical trial evaluating the use of autologous T cells genetically engineered to express B7-H3-CARs for patients ≤ 21 years old, with relapsed/refractory B7-H3+ solid tumors. This …
Phase 1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Could a fraction of the usual radiation be enough? new trial aims to reduce treatment burden for lymphoma patients.
Disease control Recruiting nowThe MIR study proved the effect of Rituximab in combination with a localized irradiation given in a standard dose. Together with the TROG 99.03 trial, this led to the recommendation of using this combined approach in early stage nodal follicular lymphoma. The GAZAI study is curre…
Phase 3 • Sponsor: Heidelberg University • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Can a Single-Day infusion save transplanted kidneys from silent scarring?
Disease control OngoingBackground: Subclinical inflammation, including borderline lesions (BL), is very common (30-40%) after kidney transplantation (KT), even in low immunological risk patients, and can lead to interstitial fibrosis/tubular atrophy (IFTA) and worsening of renal function with graft los…
Phase 4 • Sponsor: Fundación Canaria Instituto de Investigación Sanitaria de Canarias • Aim: Disease control
Last updated Sep 09, 2026 15:00 UTC
-
HIV patients may ditch daily pills for Twice-Yearly antibody shots
Disease control CompletedTMB-365 is a monoclonal antibody that binds to the CD4 receptor. TMB-380, aka VRC-07-523LS is a monoclonal antibody that binds to HIV. Both interfere with HIV entry. This study is designed to test various doses of the combination of the antibodies for safety and pharmacokinetics …
Phase 1/2 • Sponsor: TaiMed Biologics Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New drug may help kids with rare liver disease avoid transplant
Disease control OngoingAn Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat (A4250) in Children with Biliary Atresia
Phase 3 • Sponsor: Albireo, an Ipsen Company • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Ketamine shows promise for bipolar depression in new trial
Symptom relief CompletedGrowing evidence has supported rapid and robust antidepressant effects with subanesthetic doses of intravenous (IV) ketamine for treatment resistant depression (TRD). However, no completed or ongoing randomized control trials (RCTs) have evaluated the effects of repeated doses of…
Phase 2 • Sponsor: Joshua Rosenblat • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Quick HIV test at birth could get infants on better meds faster
Disease control OngoingThis study is being conducted to explore the feasibility of implementing targeted birth HIV testing of high-risk neonates using facility-based point-of-care (POC) HIV diagnostics, and to improve the ability to implement the best standard-of-care treatment possible. Infants found …
Phase 4 • Sponsor: Harvard School of Public Health (HSPH) • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Mobile clinic brings HIV treatment to the streets: Same-Day start could transform care for the excluded
Disease control CompletedImplementation of a model for access and retention of HIV care for vulnerable and excluded population using a mobile screening unit and a strategy of diagnosis and initiation of treatment with Bictegravir (BIC) 50 mg/ Emtricitabine (FTC) 200 mg / Tenofovir Alafenamide (TAF) 25 mg…
Phase 4 • Sponsor: Fundacion SEIMC-GESIDA • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Can a weekly shot tame blood sugar and weight in type 2 diabetes?
Disease control CompletedA single arm no randomized clinical trial evaluated the effectiveness and safety of once weekly semaglutide in adults with type 2 diabetes militus and obesity whose glycemic control remained inadequate despite standard therapy. participants received semaglutide for 16 weeks, begi…
Phase 4 • Sponsor: Rehman Medical Institute - RMI • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New combo therapy aims to keep High-Risk myeloma in check
Disease control Recruiting nowIxazomib combined with low-dose lenalidomide(10mg) vs Ixazomib alone as maintenance regimen in patients with high-risk multiple myeloma after induction and consolidation of VRD-based regimen.
Phase 4 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New drug cocktail shows promise for tough bile duct cancer
Disease control OngoingTo evaluate the following items in patients with advanced cholangiocarcinoma receiving lenvatinib plus paclitaxel treatment, Primary endpoint: Overall response rate (ORR) by RECIST 1.1 Secondary endpoints Progression-free survival (PFS) Time to progression Overall survival Diseas…
Phase 2 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New hope for tough brain tumors: experimental drug targets recurrent meningioma
Disease control Recruiting nowThis multi-site, Phase 2 clinical trial is an open-label study to identify the safety, pharmacokinetics, and efficacy of a repeated dose regimen of NEO100 (perillyl alcohol) for the treatment of patients with residual high-grade meningioma following resection surgery, radiographi…
Phase 2 • Sponsor: Neonc Technologies, Inc. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Can faster 911 and CPR training double cardiac arrest survival?
Knowledge-focused OngoingRACE-CARS is a real-world cluster-randomized trial designed to evaluate a multifaceted community and health systems intervention aimed to improve outcomes of out-of-hospital cardiac arrest. RACE-CARS will enroll 50 counties in North Carolina that are estimated to have a total of …
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC
-
Could a broccoli sprout compound protect aging hearts?
Disease control CancelledOur local IRB approved clinical studies seeking proof of principle for the hypothesis that SFN can be safely administered to humans at doses sufficient to protect age-associated cardiac dysfunctions. Beneficial effects of SFN-therapy will be assessed by Pre- and post-intervention…
Phase 1/2 • Sponsor: Texas Tech University Health Sciences Center • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Do unsuppressed HIV infections fuel new cases in ethiopia?
Knowledge-focused CompletedThe goal of this observational study is to understand patterns of HIV transmission in a high-prevalence area in Ethiopia, and to compare viral genetic information in people with HIV who are newly diagnosed and have not been exposed to antiretroviral therapy with persons receiving…
Sponsor: Lund University • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
New migraine drug shows promise for those caught in a Headache-Medication cycle
Disease control CompletedMedication overuse headache (MOH) is a type of headache caused by excessive use of acute headache or migraine medications (medications used to treat a headache or migraine once it begins). Treatment of MOH usually involves reducing the dose of or discontinuing acute medications. …
Phase 4 • Sponsor: H. Lundbeck A/S • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could a transplant drug help patients with rare muscle disease?
Disease control OngoingThe hypothesis is that Sirolimus, (Rapamycin (R)) which is currently used in organ transplantation and works by blocking the activity of T effector cells but preserving T regulatory cells, as well as by inducing autophagy (protein degradation), will be effective in IBM to slow or…
Phase 3 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Diabetes drug metformin tested to boost brain recovery in young cancer survivors
Symptom relief Recruiting nowThe efficacy of treatment with metformin for promoting cognitive recovery and brain growth in children/adolescents treated for a brain tumour will be investigated in a multi-site Phase III randomized double-blind placebo-controlled parallel arm superiority trial. Specifically, in…
Phase 3 • Sponsor: Donald Mabbott • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC